Trial ID or NCT#

NCT01556828

Status

NOT RECRUITING

Purpose

The goal of this study is to identify genetic changes associated with the initiation, progression, and treatment response of response of cutaneous and hematologic disorders using recently developed high-throughput sequencing technologies. The improved understanding of the genetic changes associated with cutaneous and hematologic disorders may lead to improved diagnostic, prognostic and therapeutic options for these disorders.

Official Title

Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Paul A. Khavari, MD, PhD
Dermatologist, Cutaneous oncology specialist, Medical oncologist
Carl J. Herzog Professor in Dermatology in the School of Medicine
Susan M. Swetter, MD
Dermatologist, Dermatologic oncologist, Cutaneous oncology specialist, Melanoma specialist
Professor of Dermatology at Palo Alto Veterans Affairs Health Care System and the Stanford University Medical Center
Jinah Kim
Dermatopathologist, Dermatopathologist, Surgical pathologist
Assistant Professor of Pathology and of Dermatology at the Stanford University Medical Center
Carolyn Lee MD PhD
Dermatologist, General dermatologist, Dermatologic oncologist, Cutaneous oncology specialist
Assistant Professor of Dermatology
Youn H Kim
Dermatologic oncologist, Cutaneous oncology specialist, Dermatologist
The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology) at the Stanford University Medical Center
Sumaira Z. Aasi, MD
Dermatologist, Mohs surgeon, Cutaneous oncology specialist, Surgical oncologist
Clinical Professor, Dermatology Clinical Professor (By courtesy), Surgery - Plastic & Reconstructive Surgery
Kavita Sarin
Dermatologist, General dermatologist
Assistant Professor of Dermatology at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

Alexander Ungewickell
(650) 723-6661